文献速递病毒性肝炎艾滋病与性传播感染

丙型肝炎病毒感染患者血细胞的高维免疫表型分析

High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus.
PubMed 文献 · Clin Microbiol Infect · 2021-08-30

该研究采用质谱流式技术分析慢性HCV感染者(伴或不伴HIV)及健康对照的外周血细胞群体,发现HCV感染改变了14/22(64%)的细胞群体频率,多数改变在DAA治疗获得SVR12后持续存在,提示慢性HCV及HCV/HIV感染诱导深刻而持久的先天性和适应性免疫稳态扰动。

要点

  • 慢性HCV感染显著改变外周血免疫细胞组成,涉及单核细胞、树突状细胞、NK细胞及活化T细胞等。
  • HCV/HIV共感染者的免疫细胞异常较单纯HCV感染者更明显。
  • DAA治疗获得SVR12后,多数免疫细胞改变仍持续存在。

核心结论

  • 慢性HCV及HCV/HIV感染诱导深刻且持久的先天性与适应性免疫稳态扰动。
  • DAA治疗清除病毒后12周,多数免疫细胞频率异常仍未恢复。

研究设计与样本

  • 研究纳入10名健康对照和20例HCV感染者(其中10例合并HIV),在DAA治疗前及获得SVR12后12周,用质谱流式分析22个血细胞群体。

主要发现

  • HCV感染改变了14/22(64%)的血细胞群体频率。
  • 基线时中间型单核细胞、非经典单核细胞、2型常规树突状细胞和CD56dim NK细胞频率降低35%至65%,在HCV/HIV共感染者中尤为明显。
  • 活化双阴性T细胞、活化CD4 T细胞和活化CD8 T细胞频率增加1.4至3.5倍。
  • 经Toll样受体配体刺激后,HCV感染者7/9(78%)和HCV/HIV感染者17/19(89%)的细胞因子表达条件上调。
  • 多数免疫改变在SVR12时持续存在。

关键数值与推荐

  • 中间型单核细胞频率(中位数,IQR):对照1.2(0.47-1.46),HCV 1.76(0.83-2.66),HCV/HIV 0.78(0.28-1.77)。
  • 非经典单核细胞频率:对照1.11(0.49-1.26),HCV 0.9(0.18-0.99),HCV/HIV 0.54(0.28-1.77)。
  • 2型常规树突状细胞频率:对照0.55(0.35-0.59),HCV 0.31(0.16-0.38),HCV/HIV 0.19(0.11-0.36)。
  • CD56dim NK细胞频率:对照8.08(5.34-9.79),HCV 4.72(2.59-6.05),HCV/HIV 3.61(2.98-5.07)。
  • 活化双阴性T细胞频率:对照0.07(0.06-0.10),HCV 0.10(0.09-0.19),HCV/HIV 0.19(0.12-0.25);活化CD4 T细胞:对照0.28(0.21-0.36),HCV 0.56(0.33-0.77),HCV/HIV 0.40(0.22-0.53);活化CD8 T细胞:对照0.23(0.14-0.42),HCV 0.74(0.30-1.65),HCV/HIV 0.80(0.58-1.16)。

临床怎么用

  • 临床应关注慢性HCV感染者尤其是HCV/HIV共感染者免疫细胞亚群的持续异常,DAA治疗获得SVR后仍需评估免疫恢复情况。

局限性

  • 样本量较小(共20例HCV感染者和10名对照),结论需更大规模研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Chronic hepatitis C virus (HCV) infection affects the immune system. Whether elimination of HCV with direct-acting antivirals (DAA) restores immunity is unclear. We used mass cytometry to get a broad and in-depth assessment of blood cell populations of patients with chronic HCV before and after DAA therapy. METHODS: Before and 12 weeks after sustained virological response (SVR12) to DAA therapy, 22 cell populations were analysed by mass cytometry in blood collected from ten healthy control individuals and 20 HCV-infected patients with (ten patients) or without (ten patients) human immunodeficiency virus (HIV) infection. RESULTS: HCV infection altered the frequency of 14/22 (64%) blood cell populations. At baseline, the frequencies (median, interquartile range (IQR); control, HCV, HCV/HIV) of intermediate monocytes (1.2, IQR 0.47-1.46; 1.76, IQR 0.83-2.66; 0.78, IQR 0.28-1.77), non-classical monocytes (1.11, IQR 0.49-1.26; 0.9, IQR 0.18-0.99; 0.54, IQR 0.28-1.77), conventional dendritic cells type 2 (0.55, IQR 0.35-0.59; 0.31, IQR 0.16-0.38; 0.19, IQR 0.11-0.36) and CD56dim natural killer cells (8.08, IQR 5.34-9.79; 4.72, IQR 2.59-6.05) 3.61, IQR 2.98-5.07) were reduced by 35% to 65%, particularly in HCV/HIV co-infected patients. In contrast, activated double-negative T cells (0.07, IQR 0.06-0.10; 0.10, IQR 0.09-0.19; 0.19, IQR 0.12-0.25), activated CD4 T cells (0.28, IQR 0.21-0.36; 0.56, IQR 0.33-0.77; 0.40, IQR 0.22-0.53) and activated CD8 T cells (0.23, IQR 0.14-0.42; 0.74, IQR 0.30-1.65; 0.80, IQR 0.58-1.16) were increased 1.4 to 3.5 times. Upon stimulation with Toll-like receptor ligands, the expression of cytokines was up-regulated in 7/9 (78%) and 17/19 (89%) of the conditions in HCV- and HCV/HIV-infected patients, respectively. Most alterations persisted at SVR12. CONCLUSIONS: Chronic HCV and HCV/HIV infections induce profound and durable perturbations of innate and adaptive immune homeostasis.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Herderschee J, Heinonen T, Fenwick C, et al. High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus. Clin Microbiol Infect. 2021. PMID: 34474121. doi:10.1016/j.cmi.2021.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。